These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 8769154
21. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM. Circulation; 1998 Nov 10; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899 [Abstract] [Full Text] [Related]
22. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients. Antonysamy MA, Steptoe RJ, Khanna A, Rudert WA, Subbotin VM, Thomson AW. J Immunol; 1998 Apr 15; 160(8):4106-13. PubMed ID: 9558122 [Abstract] [Full Text] [Related]
23. Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. Murase N, Fujisaki S, Tanabe M, Tsamandas AC, Todo S, Starzl TE, Demetris AJ. Transplant Proc; 1994 Jun 15; 26(3):1517-8. PubMed ID: 7518139 [No Abstract] [Full Text] [Related]
24. The impact of portal infusion with donor-derived bone marrow cells and intracellular cytokine expression of graft-infiltrating lymphocytes on the graft survival in rat small bowel transplant model. Mitsuoka N, Iwagaki H, Ozaki M, Sheng SD, Sadamori H, Matsukawa H, Morimoto Y, Matsuoka J, Tanaka N, Yagi T. Transpl Immunol; 2004 Nov 15; 13(3):155-60. PubMed ID: 15381197 [Abstract] [Full Text] [Related]
25. Impact of tacrolimus and bone marrow augmentation on intestinal allograft survival and intragraft cytokine expression in rats. Nakao A, Kobayashi E, Shen SD, Yoshino T, Tanaka N. J Med; 2001 Nov 15; 32(3-4):207-30. PubMed ID: 11563819 [Abstract] [Full Text] [Related]
26. Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer. Muramatsu K, Valenzuela RG, Bishop AT. J Orthop Res; 2003 Nov 15; 21(6):1056-62. PubMed ID: 14554219 [Abstract] [Full Text] [Related]
27. Effect of FK 506 on graft survival in rat small intestinal allografts. Date K, Okajima K, Takeda Y, Isozaki H, Tezuka K, Ryo T. Transplant Proc; 1992 Jun 15; 24(3):1173. PubMed ID: 1376516 [No Abstract] [Full Text] [Related]
28. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells. Nakao A, Nalesnik MA, Ishikawa T, Azhipa O, Demetris AJ, Murase N. Transplantation; 2003 May 15; 75(9):1575-81. PubMed ID: 12792518 [Abstract] [Full Text] [Related]
30. DNA released from rejecting organs is an indicator of the degree of graft cellular damage. Interewicz B, Olszewski WL, Stanislawska J, Sikora M, Durlik M, Maksymowicz M. Transplant Proc; 2005 May 15; 37(1):98-101. PubMed ID: 15808560 [Abstract] [Full Text] [Related]
31. Donor bone marrow in laryngeal transplantation: results of a rat study. Khariwala SS, Dan O, Lorenz RR, Klimczak A, Siemionow M, Strome M. Am J Otolaryngol; 2008 May 15; 29(4):242-9. PubMed ID: 18598835 [Abstract] [Full Text] [Related]
32. Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation. Llull R, Murase N, Demetris AJ, Ye Q, Manez R, Starzl TE. Transplant Proc; 1995 Aug 15; 27(4):2363-4. PubMed ID: 7544504 [No Abstract] [Full Text] [Related]
33. Microchimerism and heart allograft acceptance. Masaki Y, Hirasawa A, Okuyama S, Tsujimoto G, Iwaya M, Li XK, Yokoi Y, Nakamura S, Baba S, Miyamoto M. Transplant Proc; 1995 Feb 15; 27(1):148-50. PubMed ID: 7878949 [No Abstract] [Full Text] [Related]
34. Combined effect of donor-specific bone marrow transplantation via portal vein and FK506 on small bowel transplantation in the rat. Nakao A, Yagi T, Matsukawa H, Endo A, Okada Y, Sun DS, Sadamori H, Inagaki M, Matsuno T, Tanaka N. Transplant Proc; 2000 Nov 15; 32(7):2011-2. PubMed ID: 11120044 [No Abstract] [Full Text] [Related]
35. Chimeric liver established by recipient type bone marrow cell transplantation to donor before to liver transplantation produces marked suppression of allograft rejection in rats. Sanada O, Sumimoto R, Fukuda Y, Kaneda K, Ito H, Asahara T, Dohi K. Transplant Proc; 1999 Nov 15; 31(1-2):704-6. PubMed ID: 10083304 [No Abstract] [Full Text] [Related]
36. Contribution of passenger leukocytes to the induction and maintenance of heart allograft acceptance. Ko S, Deiwick A, Dinkel A, Wonigeit K, Schlitt HJ. Transplant Proc; 1999 Nov 15; 31(1-2):158-9. PubMed ID: 10083056 [No Abstract] [Full Text] [Related]
37. Immunosuppressive mechanism and immune tolerance of FK 506 in rat small bowel transplantation. Nakai T, Kawabe T, Satoh S, Kurooka K, Yasutomi M. Transplant Proc; 1996 Apr 15; 28(2):1091-3. PubMed ID: 8623237 [No Abstract] [Full Text] [Related]
38. Prognostic value of tissue neurotensin levels in the survival of small bowel transplants. Schlemminger R, Gieseler RK, Klemp F, Bredt M, Mentlein R, Kuhn R, Nustede R, von Gaudecker B, Peters JH. Transplant Proc; 1994 Jun 15; 26(3):1615-7. PubMed ID: 8030058 [No Abstract] [Full Text] [Related]
39. Functional relevance of donor-derived hematopoietic microchimerism only for induction but not for maintenance of allograft acceptance. Ko S, Deiwick A, Dinkel A, Wonigeit K, Schlitt HJ. Transplant Proc; 1999 Jun 15; 31(1-2):920-1. PubMed ID: 10083405 [No Abstract] [Full Text] [Related]
40. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S, Ulusal BG, Ulusal AE, Izycki D, Yoder B, Siemionow M. Transplant Proc; 2006 Jun 15; 38(5):1625-33. PubMed ID: 16797371 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]